WHO classification and molecular diagnostics of central nervous system tumors;WHO-klassifikation und molekulare diagnostik von tumoren des zentralen nervensystems

Nervenheilkunde

Volumn 28, Issue 9, 2009, Pages 611-618

  Riemenschneider, Markus J ^a   Reifenberger, G ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

1p 19q; Classification; Glioma; IDH1; MGMT; Molecular diagnostics

Indexed keywords

B RAF KINASE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ASTROCYTOMA; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME DELETION; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; GENE; GENE DUPLICATION; GENE TRANSLOCATION; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGIC SKIN REACTION; HUMAN; IDH1 GENE; METHYLATION; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; OLIGODENDROGLIOMA; REVIEW; TUMOR CLASSIFICATION; WORLD HEALTH ORGANIZATION;

EID: 69549111378     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1628693     Document Type: Review

References (46)

1. Balss J et al. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 2008; 116: 597-602.
2. Bar EE et al. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol 2008; 67: 878-887.
3. Brat DJ et al. Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol 2007; 17: 319-324.
4. Brat DJ et al. Pituicytoma: a distinctive low-grade glioma of the neurohypophysis. Am J Surg Pathol 2000; 24: 362-368.
5. Cairncross G et al. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 2006; 24: 2707-2714. (Pubitemid 46630566)
6. Cairncross JG et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998; 90: 1473-1479.
7. Dahiya S et al. Spindle cell oncocytoma of the adenohypophysis: report of two cases. Acta Neuropathol 2005; 110: 97-99. (Pubitemid 41131202)
8. Deshmukh H et al. High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas. Oncogene 2008; 27: 4745-4751.
9. Griffin CA et al. Identification of der(1;19) (q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss. J Neuropathol Exp Neurol 2006; 65: 988-994.
10. Hegi ME et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352: 997-1003.
11. Jeibmann A et al. Prognostic implications of atypical histologic features in choroid plexus papilloma. J Neuropathol Exp Neurol 2006; 65: 1069-1073. (Pubitemid 44684664)
12. Jones DT et al. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 2008; 68: 8673-8677.
13. Jouvet A et al. Papillary tumor of the pineal region. Am J Surg Pathol 2003; 27: 505-512.
14. Kleihues P, Burger PC, Scheithauer BW (Hrsg). Histological typing of tumours of the central nervous system. World Health Organization international histological classification of tumours. Heidelberg: Springer 1993.
15. Kleihues P, Cavenee WK (Hrsg). World Health Organization Classification of Tumours. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press 2000.
16. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1999; 1: 44-51.
17. Kloub O et al. Spindle cell oncocytoma of the adenohypophysis: report of two recurrent cases. Am J Surg Pathol 2005; 29: 247-253. (Pubitemid 40170644)
18. Komori T et al. Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. Am J Surg Pathol 1998; 22: 1171-1183. (Pubitemid 28462765)
19. Komori T, Scheithauer BW, Hirose T. A rosette-forming glioneuronal tumor of the fourth ventricle: infratentorial form of dysembryoplastic neuroepithelial tumor? Am J Surg Pathol 2002; 26: 582-591.
20. Lellouch-Tubiana A et al. Angiocentric neuro-epithelial tumor (ANET): a new epilepsy-related clinicopathological entity with distinctive MRI. Brain Pathol 2005; 15: 281-286. (Pubitemid 41677426)
21. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (Hrsg). WHO Classification of tumours of the central nervous system. Lyon: IARC 2007.
22. Louis DN et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109.
23. Miller CR et al. Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas. J Clin Oncol 2006; 24: 5419-5426.
24. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol (Berl) 2005; 109: 93-108.
25. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005; 64: 479-489. (Pubitemid 40781150)
26. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol 2007; 170: 1445-1453. (Pubitemid 47339290)
27. Parsons DW et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807-1812.
28. Pfister S et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 2008; 118: 1739-1749. (Pubitemid 351632377)
29. Preusser M et al. Angiocentric glioma: report of clinico-pathologic and genetic findings in 8 cases. Am J Surg Pathol 2007; 31: 1709-1718. (Pubitemid 350287569)
30. Reifenberger G, Louis DN. Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 2003; 62: 111-126. (Pubitemid 36176946)
31. Riemenschneider MJ, Reifenberger G. Astrocytic tumors. Recent Results Cancer Res 2009; 171: 3-24.
32. Riemenschneider MJ, Reifenberger G. Molecular neuropathology of gliomas. Int J Mol Sci 2009; 10: 184-212.
33. Roncaroli F, Scheithauer BW. Papillary tumor of the pineal region and spindle cell oncocytoma of the pituitary: new tumor entities in the 2007 WHO Classification. Brain Pathol 2007; 17: 314-318.
34. Roncaroli F et al. Spindle cell oncocytoma' of the adenohypophysis: a tumor of folliculostellate cells? Am J Surg Pathol 2002; 26: 1048-1055.
35. Rosenblum MK. The 2007 WHO Classification of Nervous System Tumors: newly recognized members of the mixed glioneuronal group. Brain Pathol 2007; 17: 308-313.
36. Schiffer D et al. Histologic prognostic factors in ependymoma. Childs Nerv Syst 1991; 7: 177-182.
37. Stupp R et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 434-435.
38. Stupp R et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-996. (Pubitemid 40349501)
39. Tihan T et al. Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol 1999; 58: 1061-1068. (Pubitemid 29468267)
40. Ulm AJ et al. Pituicytoma: report of two cases and clues regarding histogenesis. Neurosurgery 2004; 54: 753-757.
41. Vajtai I, Sahli R, Kappeler A. Spindle cell oncocytoma of the adenohypophysis: report of a case with a 16-year follow-up. Pathol Res Pract 2006; 202: 745-750. (Pubitemid 44356426)
42. van den Bent MJ et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 2006; 24: 2715-2722.
43. Wang M et al. Monomorphous angiocentric glioma: a distinctive epileptogenic neoplasm with features of infiltrating astrocytoma and ependymoma. J Neuropathol Exp Neurol 2005; 64: 875-881. (Pubitemid 41434670)
44. Watanabe T et al. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 2009; 174: 1149-1153.
45. Yan H et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009; 360: 765-773.
46. Zülch KJ (Hrsg). Histological typing of tumours of the central nervous system. Geneva: World Health Organization 1979.